Introduction
The Hedgehog (Hh) pathway is a major developmental signaling pathway essential for the growth and patterning of various tissues during embryonic development and adult tissue homeostasis [1, 2] . Malfunction of this pathway has been implicated in numerous human disorders including congenital anomalies and cancers [1, 2] . The hedgehog (hh) gene was first identified as an embryonic segment polarity gene in Drosophila [3] . Three Hh family members have been identified in mammals including Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert Hedgehog. Key components of the Hh signaling pathway include the 12-transmembrane receptor Patched (Ptc) that functions as the Hh receptor, the seven-transmembrane protein Smoothened (Smo) that functions as the obligated Hh signal transducer, and the Zincfinger transcription factor Cubitus interruptus (Ci)/Gli [4] . In the absence of Hh ligands, Ptc blocks the activity of Smo and full-length Ci/Gli is phosphorylated by multiple kinases including PKA, CK1 and GSK3β, which targets it for Slimb/β-TRCP-mediated proteolysis to generate its repressor form (Ci R /Gli R ) [5] . In the presence of Hh, the Ptc inhibition of Smo is released through Hh binding to Ptc; Smo is phosphorylated by multiple kinases including PKA (Drosophila only), CK1 and Gprk2 kinases, which promotes its active conformation and changes its subcellular localization with Drosophila Smo accumulating on the cell surface and mammalian Smo accumulating in the primary cilium [6] [7] [8] [9] [10] [11] . Ci/Gli phosphorylation and prote- olysis is blocked, leading to diminished Ci R /Gli R activity [12] [13] [14] . In addition, full-length Ci/Gli is converted into its activator form (Ci A /Gli A ) [15] . Although Smo is activated through a conserved mechanism in Drosophila and mammals [7, 9] , the mechanisms by which activated Smo transduces the signal to the downstream signaling components appear to diverge. In Drosophila, Smo forms a complex with the kinesinlike protein Costal2 (Cos2) and the Ser/Thr kinase Fused (Fu) in a manner regulated by Hh and Smo phosphorylation [16, [17] [18] [19] [20] [21] . Hh-induced Smo conformational switch and C-tail dimerization lead to Fu dimerization, phosphorylation and activation [20] [21] [22] . Activated Fu regulates both the activator and repressor form of Ci, likely by phosphorylating Cos2 and Sufu [18, [20] [21] [22] [23] . Both Sufu and the mammalian homolog of Cos2, Kif7, are involved in Hh signaling [24] [25] [26] [27] [28] . By contrast, the mammalian homolog of Fu is not required for Hh signaling during development [29, 30] . Moreover, there is no evidence that Kif7 physically interacts with mammalian Smo. Hence, the signaling component acting immediately downstream of mammalian Smo has remained unknown.
EVC and EVC2 are adjacent genes identified in the recessive skeletal dysplasia Ellis-van Creveld syndrome (EvC; MIM: 225500), and loss-of-function mutation in either gene leads to the same condition [31] [32] [33] [34] . Recent studies indicate that Evc promotes chondrocyte proliferation, hypertrophy and the differentiation of osteoblasts in the perichondrium, and localizes to the primary cilia of osteoblasts to mediate Hh signaling in the osteoblast lineage [35] . EVC2, which is in close proximity to EVC, was also implicated as a positive regulator of Hh signaling. Evc and Evc2 associate with each other and colocalize at primary cilia in a mutually dependent manner [36] . The mechanism by which Evc/Evc2 regulate Hh signaling has remained unknown. Here, we provide evidence that Evc/Evc2 act downstream of Smo to promote Gli activation. We find that knockdown of Evc/Evc2 attenuates Hh signaling without affecting Smo phosphorylation and ciliary localization. In contrast, knockdown of Evc/Evc2 does not affect Hh pathway activation caused by Gli overexpression or loss of Sufu, indicating that Evc/Evc2 function upstream of Sufu and Gli to regulate Hh signaling. We provide evidence that Evc/Evc2 are required for Gli activation and inhibition of Gli processing to generate the truncated Gli repressors. We show that Hh induces a physical interaction between Smo and Evc/ Evc2 and that this association depends on phosphorylation of the Smo C-terminal intracellular tail. Together, our results suggest that Evc/Evc2 transduce Hh signal downstream of Smo activation and promote Gli activation by antagonizing Sufu.
Results

EVC/EVC2 knockdown attenuates Hh signaling
Previous studies demonstrated that Evc is essential for Ihh signaling in the cartilage growth plate, and Evc2, a close homolog of Evc, is a positive modulator of Shh signaling in cultured cells [36, 37] . To define the underlying mechanism by which Evc/Evc2 modulate Hh signaling, we employed the RNAi approach to inactivate the two genes. We designed two independent shRNAs each against EVC and EVC2 (Supplementary information, Figure S1 ). We first confirmed the positive role of Evc/Evc2 in the Hh signaling pathway using 8× GliBS luciferase (Gli-luc) assay in NIH3T3 cells. In line with previous findings [36] , knockdown of Evc/Evc2 using two independent shRNAs in NIH3T3 cells attenuated the activation of Gli-luc reporter gene induced with Shh or a Smo agonist SAG ( Figure 1A and 1B, top). The knockdown efficiency of Evc/Evc2 by these shRNAs was determined by real-time PCR and over 70% reduction was achieved for each shRNA ( Figure 1A and 1B, bottom).
Smo phosphorylation and ciliary localization are not blocked by Evc/Evc2 inactivation
Our previous studies have demonstrated that Smo is hyperphosphorylated at multiple sites in its C-terminal tail by CK1α and GRK2 kinases upon Shh stimulation and that these phosphorylation events activate Smo through promoting its open active conformation and ciliary accumulation [9] . Evc/Evc2 knockdown could attenuate Shh signaling by downregulating Shh-induced Smo activation. Alternatively, Evc/Evc2 could act at a step downstream of Smo after it is activated by Hh. To distinguish these two possibilities, we examined whether inactivation of Evc/Evc2 affected Smo phosphorylation and ciliary accumulation. To monitor Smo phosphorylation, we took advantage of a phospho-specific antibody (PS1) that recognizes the S1 phosphorylation cluster (pS615ADVpS619pS620) in Smo C-tail, which plays a major role in Smo activation [9] . To monitor Smo ciliary localization, we made use of an NIH3T3 cell line that stably expresses CFP-tagged Smo (NIH3T3 Smo-CFP ) [9] . Consistent with our pervious findings, Smo-CFP did not exhibit significant ciliary localization in the absence of Shh, but accumulated in the primary cilia upon Shh stimulation (Figure 2A and 2B ). By immunostaining with the PS1 antibody, we found that PS1 signal was not detected in primary cilia of NIH3T3 Smo-CFP Figure 2B and 2G). We confirmed that Evc/Evc2 knockdown did not block Hhinduced Smo phosphorylation by western blot analysis using the PS1 antibody ( Figure 2H ). Since Smo phosphorylation and primary cilia accumulation are indicative for its activation, these data suggest that Evc and Evc2 do not participate in Hh-induced Smo activation.
Inactivation of Evc/Evc2 inhibits Hh pathway activity downstream of activated Smo
Previous work has implicated that Evc/Evc2 are required for Hh-and Smo agonist-induced pathway activation, suggesting that they act at the level of Smo in Hh signal transduction; however, it did not distinguish whether Evc/Evc2 are required for Smo activation or signal transduction downstream of activated forms of Smo [36, 37] . Our above observations suggest that Evc/Evc2 act at a step downstream of Smo after it is phosphorylated in response to Hh. To further test this hypothesis, we asked whether inactivation of Evc/Evc2 affects Hh signal transduction from constitutively active forms of Smo: SmoSD0-5 (SmoSD for short) in which all six phosphorylation clusters were converted to acidic residues to mimic phosphorylation; SmoA1 (also known as SmoM2), which is an oncogenic form of Smo; and SmoA1SD0-5 (SmoA1SD), which combines both the A1/M2 and SD0-5 mutations [9] . SmoSD, SmoA1, and SmoA1SD were transfected into NIH3T3 cells with the Gli-luc reporter gene in the presence or absence of Evc/Evc2 shRNAs. The transfected cells were treated with or without Shh-conditioned media, followed by dual luciferase assay. In line with our previous findings 
Evc/Evc2 act upstream of Sufu to regulate Gli activity
Sufu is a major inhibitory component of the mammalian Hh pathway downstream of Smo as loss of Sufu leads to ectopic Hh signaling activation similar to loss of Ptc [28] . We next asked whether Evc/Evc2 are required for the constitutive Hh signaling activity in the absence of Sufu, and we made use of Sufu −/− MEF cells [28] . We compared the Gli-luc response between WT MEF and Sufu −/− MEF cells, and found that loss of Evc/Evc2 by shRNAs attenuated Shh-induced Gli-luc activation in WT MEFs ( Figure 4A ), but did not affect the constitutive
Gli-luc activity in Sufu
−/− cells regardless of the presence or absence of Shh ( Figure 4B ). Introducing a Sufu expression construct back into Sufu −/− cells suppressed the high basal Gli-luc activity and restored the dependency on Evc/Evc2 for Shh-induced activation of Gli-luc ( Figure  4C ), suggesting that Evc/Evc2 are dispensable for the constitutive Gli activity in Sufu −/− cells. Hh signaling activates the Gli transcription factors by inhibiting the production of Gli R and promoting the formation of Gli A . We therefore determined whether these processes are affected by inactivation of Evc/Evc2. We made use of cell lines that stably express Flag-tagged Gli2 (Shh-EGFP FLAG-Gli2 ) or Gli1 (Shh-LIGHT2 FLAG-Gli1 ) [38] . Consistent with a previous study [38] , Shh induced accumulation of Flag-Gli1 and Flag-Gli2 at the tip of primary cilia, which is indicative of Gli activation (Figure 5B, 5H and Supplementary information, Figure S3 ). When cells are infected with high-titer Evc/Evc2 shRNA expression viruses, the accumulation of Flag-Gli1 and Flag-Gli2 at the tip of primary cilia was significantly reduced ( Figure 5C -5F, 5I-5L and Supplementary information, Figure S3 ), suggesting that Gli activation is attenuated by inactivation of Evc/Evc2. The knockdown efficiencies for shRNA viruses were verified in the same batch of cells used in the above experiments (data not shown). Furthermore, we collected the cells for western blot analysis to determine whether Evc/Evc2 are required for Shh to inhibit the formation of Gli R . In the absence of Shh, Flag-Gli2 was processed into a truncated repressor form (Gli2 R ) while treating cells with Shh-conditioned medium inhibits Gli2 R formation ( Figure 5M ), resulting in a 4-fold increase in the ratio of Gli2 FL /Gli2 R ( Figure  5N ). Consistent with a previous finding [37] , we found that Evc/Evc2 RNAi had little if any effect on Gli2 R formation in the absence of Shh, suggesting that Evc/ Evc2 are not required for Gli processing to generate the repressor forms. However, we found that Shh did not effectively block the production of Gli2 R in the absence of Evc/Evc2 ( Figure 5M and 5N) , suggesting that Evc/Evc2 are required for Hh to inhibit Gli2 R formation in cultured cells. A previous study indicated that Shh can still block Gli repressor formation in the absence of Evc function in vivo [37] . It is possible that Hh-mediated inhibition of Gli processing is more dependent on Evc/Evc2 in vitro, whereas redundant or context-dependent mechanisms may exist in vivo. In addition, only a fraction of cells are exposed to Hh in vivo and a partial change in Gli processing in Evc/Evc2 mutants could have been "masked", whereas in cell-based assays, all cells are exposed to Hh, and as a consequence, it might be more sensitive to detect the effect of Evc/Evc2 inactivation on Shh-regulated Gli processing. Taken together, these data suggest that Evc/Evc2 regulate the balance of Gli A and Gli R by promoting Gli A activation while inhibiting Gli R formation.
Hh-induced phosphorylation of Smo promotes its binding to Evc/Evc2
Evc and Evc2 associate with each other and their localization in primary cilia appears to be mutually dependent [36] . Smo is also accumulated in primary cilia in response to Shh, which depends on its phosphorylation by CK1 and GRK2 [9] . Our epistasis experiments suggest that Evc/Evc2 act downstream of Smo activation to regulate Hh pathway activity (Figures 2 and 3) . To gain further insight into the mechanism by which Evc and Evc2 exert their function, we decided to test the possibility that they form a complex with Smo Figure S4 ). Taken together, these observations suggest Shh-induced phosphorylation of Smo is both necessary and sufficient to recruit Evc/Evc2, and the binding between Smo and Evc/Evc2 is mediated by Smo C-tail and is likely dependent on primary cilia.
Several studies have shown that Kif7, the mammalian homolog of Drosophila Cos2, is involved in Hh signaling [24] [25] [26] [27] . In Drosophila, Hh-induced Smo phosphorylation and conformational change promotes Smo/Cos2 association [20, 21] . Interestingly, we found that Hh and oncogenic Smo mutation can promote the recruitment of Kif7 to Smo in a manner depending on Evc/Evc2 and Smo phosphorylation (Figure 6B ), suggesting that Kif7 is recruited to the activated Smo/Evc/Evc2 complex.
Discussion
Despite that great efforts have been devoted to understand how Hh signaling works in the past two decades, the mechanism by which mammalian Hh signals are transduced from Smo to the Gli transcription factors is still poorly understood [1] . Most notably, the component acting immediately downstream of mammalian Smo has remained elusive, and thus represents a major gap in the mammalian Hh signaling pathway. Here, we demonstrated that the Evc/Evc2 complex, the products of two human disease genes responsible for the Ellis-van Creveld syndrome, mediates Hh signal transduction from Smo to the Gli transcription factors. We demonstrated that Shh induces binding of Evc/Evc2 to Smo, depending on phosphorylation of its C-tail. Furthermore, we provide evidence that Evc and Evc2 act upstream of Sufu to regulate Gli activity. We propose that Hh-induced phosphorylation of Smo (Figure 7) . Our findings thus provide a novel insight into how activated Smo relays the Hh signal to downstream signaling components in the primary cilium.
The microtubule-based organelle primary cilium has been implicated as essential for mammalian Hh signal transduction, and most of Hh signaling components including Ptc, Smo and Gli proteins exhibit dynamic ciliary localization [39] . For example, Hh-induced Smo phosphorylation promotes its ciliary localization and active conformation [9] . Evc and Evc2 form a complex localized in the primary cilia and both proteins have been implicated as positive regulators of mammalian Hh signaling [36, 37] . We found that inactivation of Evc/Evc2 does not significantly affect Hh-induced Smo phosphory- Figure 6B ). We propose that Hh induces the formation of an active Smo/Evc/Evc2 signaling complex in the primary cilia to transduce the signal intracellularly, leading to the activation of Gli proteins ( Figure 7) .
It has been shown that Sufu retains Gli in the cytoplasm and promotes its proteolysis into a truncated repressor whereas activation of Smo in primary cilia upon Hh stimulation leads to recruitment of endogenous SufuGli complexes to the cilia and causes the dissociation of Sufu-Gli complex, allowing activated Gli proteins to enter the nucleus [40] [41] [42] . We found that Evc and Evc2 function upstream of Sufu to promote Gli activation. Hence, it is possible that the activated Smo/Evc/Evc2 complex may modulate the association between Sufu and Gli proteins in the primary cilia.
We have obtained evidence that Hh stimulates the binding of Kif7 to Smo, which is facilitated by Evc/Evc2. Increased binding of Cos2 to activated Smo has also been observed in Drosophila [20, 21] . It has been shown that binding of Cos2 to activated Smo promotes Fu dimerization, phosphorylation and activation, and activated Fu then regulates Ci by inhibiting its repressor form and stimulating its activator form [20] [21] [22] . The mammalian Fu homolog is dispensable for Hh signaling [29, 30] ; however, it is possible that another kinase(s) may substitute for the Fu function in the mammalian Hh pathway. It has been shown that Hh stimulates Gli3 phosphorylation, which correlates with formation of Gli3
A [40] . Therefore, it would be interesting to determine whether Hh-induced Gli3 phosphorylation is affected by loss of Evc/Evc2. It is tempting to speculate that the activated Smo/Evc/Evc2 complex may recruit one or more kinases to phosphorylate Gli proteins and promote their activation.
The data from mouse Evc KO experiments and human patients clearly established a role for Evc proteins in Ihh signaling [37] . The "extra toe" phenotype in human patient suggests that Evc/Evc2 may also play a role in Shh pathway although they might not be absolutely required for Shh signaling. Our in vitro study also suggested that Evc/Evc2 are only required for maximal Hh pathway activity because residual pathway activities persisted when Evc and Evc2 were knocked down. It remains to be determined whether Evc mutants exhibit any defects in Shh responses in vivo.
Materials and Methods
Constructs, cell culture, transfection, immunoprecipitation, western blot and small molecule treatment
WT or mutant Smo DNA fragments were amplified by PCR and inserted between HindIII and SalI digestion sites into the pGE vector; Myc tag was PCR amplified and inserted in frame after Smo coding sequence; all the constructs were sequence verified; Smo mutants have been described previously [9] . Independent shRNAs against EVC and EVC2 were constructed using pLKO.1 vector, and constructs were sequence verified. Lentiviruses were generated according to the manufacturer's protocol; supernatants containing different lentiviruses were collected 48 and 72 h post transfection, cells were infected twice with 48 h and 72 h viruses with 4 μg/ml polybrene, respectively. 21-bp targeting sequences are indicated in Supplementary information, Figure S1 . NIH3T3 cells were obtained from ATCC; HEK-293T were kindly provided by Dr Alec Zhang; and Sufu −/− MEFs cells and Kif7-GFP construct were kindly provided by Dr Chi-Chuang Hui. All the mammalian cells were cultured in DMEM supplemented with 10% fetal bovine serum and incubated at 37 °C. For protein expression, the mammalian cells were transfected with X-tremeGENE transfection reagent (Roche) according to the manufacturer's instructions, harvested and lysed in RIPA buffer (50 mM Tris-Cl pH 7.9, 150 mM NaCl, 5 mM EDTA, 1% NP-40 supplemented with protease inhibitors (Roche)). Lysates were frozen and thawed 2~3 times. Immunoprecipitation experiments were performed as previously described [14] . Primary and second antibodies used are: mouse anti-Myc (Sigma), mouse anti-Flag (Santa Cruz Biotechnology), monoclonal anti-acetylated tubulin (Sigma, #T7451), PS1 phospho-specific antibody (1:50 [9] ), goat anti-mouse IgG HRP, goat anti-rabbit IgG HRP. Reagents used were: Recombinant Mouse Sonic Hedgehog N-terminus (ShhNp, R&D Systems, Cat # 464-SH), 293-Shh-conditioned medium (1:6 v/v [43] ), and SAG (200 nM).
8× GliBS-luciferase assay
Luciferase assay was performed following standard protocol described in [9] . Briefly, the day before transfection, cells were seeded at a density of 1~2 × 10 5 cells/ml, and transfected with a 4:1 ratio of 8× GliBS-luciferase vector:pRL-TK and other transgene or www.cell-research.com | Cell Research 
Immunofluorescence
Cells were seeded on poly-D-Lysine coated LAB-TEK chamber slides and infected twice with Evc/Evc2 shRNA viruses, followed by treating with the indicated reagents for the indicated time. Cells were washed 3 times with 1× PBS and fixed with 4% PFA, stained and observed using Zeiss LSM510 confocal microscope.
